Using virtual reality to help stroke patients with hemineglect
Effect of Immersive Virtual Reality With Multisensory Stimulation on the Functional Impact of Hemineglect Secondary to a Right-Sided Stroke: A Single Case Experimental Design (SCED) Study
This study is testing if using virtual reality with sensory stimulation can help stroke patients with hemineglect improve their ability to notice and respond to things on one side of their environment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 3 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Hopital La Musse Academic / other |
| Locations | 1 site (Saint-Sébastien-de-Morsent) |
| Trial ID | NCT06719063 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the effects of immersive virtual reality combined with multisensory stimulation on patients suffering from hemineglect following a right-sided stroke. Hemineglect is a cognitive impairment that affects a significant number of stroke survivors, leading to difficulties in orienting and responding to stimuli on one side of their environment. The study aims to assess whether this innovative rehabilitation approach can enhance functional outcomes and improve the quality of life for affected individuals. Participants will be evaluated based on their response to the virtual reality intervention over a specified period.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old who have experienced a first ischemic right stroke within the last three months and exhibit left hemineglect.
Not a fit: Patients with a history of neurological or psychiatric illnesses, severe cognitive disorders, or those currently pregnant or breastfeeding may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve rehabilitation outcomes for stroke patients with hemineglect, enhancing their daily functioning and autonomy.
How similar studies have performed: While the use of virtual reality in rehabilitation is gaining traction, this specific application for hemineglect post-stroke is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient aged over 18 years * Diagnosis of first ischemic right stroke established by a neurologist using clinical examination and brain imaging (CT scan or MRI) * Stroke occurring less than 3 months ago * Presence of left hemineglect, diagnosed using the Neglect Assessment Battery (NAB) * Normal vision or corrected to normal * Patient affiliated with the social security system Exclusion Criteria: * History of neurological or psychiatric illness * Epilepsy * Craniotomy * Limited range of cervical motion due to orthopedic disorders * Moderate or severe deafness (hearing loss of 40 dB in one ear, as measured by tonal audiometry) * Anosmia (loss of smell) * Asthmatic disease * Pregnant women or women suspected of being pregnant * Breastfeeding women * Severe neurocognitive disorders with an MMSE score \< 21 * Patient under legal protection measures * Minor patient * Patient enrolled in another research protocol
Where this trial is running
Saint-Sébastien-de-Morsent
- Hôpital La Musse — Saint-Sébastien-de-Morsent, France (Recruiting)
Study contacts
- Study coordinator: Héloïse BAILLET, PhD
- Email: h.baillet@hlrs-lamusse.net
- Phone: +33(0)232293047
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.